Financing - January 31, 2020
Follicum receives Vinnova grant
Follicum’s grant application to Vinnova to study binding of FOL peptides to receptors on pancreatic cells has been approved. Follicum is the coordinator of the project, which also includes Lund University and SARomics Biostructures. Parts of the project involve advanced analysis work to be performed at the new MAX IV synchrotron facility in Lund. Aims […]
Clinical Trials - January 30, 2020
Follicum’s Phase II study approved by the German Medicines Agency
Follicum has received approval from the German Medicines Agency (BfArM) and the German Ethics Committee to start a Phase IIa clinical study with a topical formulation of FOL-005 on patients with alopecia (hair loss). The trial will comprise about 200 patients who will be treated with FOL-005 or placebo daily for 4 months. The study […]
Intellectual Property - December 17, 2019
Follicum receives patent grant in the US
Follicum announced on September 17, 2019 that the company had received a Notice of Allowance from the US Patent and Trademark Office regarding the patent application “Novel Compositions and Uses Thereof”. The patent has now formally been granted by the USPTO. The patent is valid until 2032. In this patent family, Follicum already has two […]
Clinical Trials - November 12, 2019
Follicum collaborates with proDERM
Follicum has announced that the company has signed a collaboration agreement with proDERM for conducting the new clinical trial with a cream-like formulation of FOL-005 to be tested on alopecia patients (patients with hair loss). The company expects to be ready for starting the clinical trial shortly after the turn of the year. Preparations for […]
Financing - October 24, 2019
Follicum receives Eurostars grant
The company’s application for a Eurostars grant comprising the development of a treatment for diabetes has been approved. Follicum is the coordinator of the project. Other partners include Lund University, Bioassay Labor für biologische Analytik GmbH and Deutsche Diabetes-Forschungsgesellschaft (DDZ). Additional resources for the company’s development of a peptide-based treatment of diabetes The grant comprising […]
Intellectual Property - May 8, 2019
Follicum receives patent grant in Europe
The company has received an official grant of patent from the European Patent Office, EPO regarding the company’s broadened patent application for stimulation of hair growth. The official grant follows the “Intention to Grant” which was communicated on November 21, 2018. With EPO’s grant of patent no. EP 3087999 B1, there is now broad protection […]
